Measurable residual disease in chronic lymphocytic leukemia

Measurable residual disease (MRD) is defined as the presence of residual cancer cells after treatment in patients with clinically undetectable disease, who would otherwise be considered in complete remission. It is a highly sensitive parameter which indicates the disease burden and predicts survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Benintende, Giulia, Pozzo, Federico, Innocenti, Idanna, Autore, Francesco, Fresa, Alberto, D’Arena, Giovanni, Gattei, Valter, Laurenti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971803/
https://www.ncbi.nlm.nih.gov/pubmed/36865804
http://dx.doi.org/10.3389/fonc.2023.1112616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971803/
https://www.ncbi.nlm.nih.gov/pubmed/36865804
http://dx.doi.org/10.3389/fonc.2023.1112616

Ejemplares similares